It's your health: Use your medications safely

Journal of Women's Health

Volumn 14, Issue 1, 2005, Pages 16-18

  Correa de Araujo, Rosaly ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; HERBACEOUS AGENT; HORMONE; NON PRESCRIPTION DRUG;

ARTICLE; BIRTH DEFECT; CONSULTATION; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG USE; FEMALE; FOOD DRUG INTERACTION; HEALTH BEHAVIOR; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; MENOPAUSE; PHARMACEUTICAL CARE; PREGNANCY; PRIMARY PREVENTION; PRIORITY JOURNAL; RESPONSIBILITY; SEX DIFFERENCE;

EID: 14644395009     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2005.14.16     Document Type: Article

References (19)

1. Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use patterns. Ann Pharmacother 2002;36:30.
2. Correa-de-Araujo R, Miller GE, Banthin JS, Trink Y. Gender differences in drug use and expenditures in a privately insured population of older adults. J Wom Health 2005;14:73.
3. Harris D, Douglas P. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung and Blood Institute. N Engl J Med 2000; 342:475.
4. Wizeman T, Pardue M-L, eds. Exploring the biological contributions to human health. Does sex matter? Washington, DC: Institute of Medicine, 2001, Report No. ASBN 0-309-07281-6.
5. Anderson GD. Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Wom Health 2005;19.
6. Carlson KJ, Eisenstat SA, Frigoletto FD Jr, Schiff I. Primary care of women, 2nd ed. St. Louis, MO: Mosby, 2002:8.
7. Legato MJ. Principles of gender-specific medicine. San Diego, CA: Elsevier Academic Press, 2004;2:825.
8. Anthony M. Male/female differences in pharmacology: Safety issues with QT prolonging drugs. J Wom Health 2005;14:47.
9. Wolbrette DL. Drugs that cause torsades de pointes and increase the risk of sudden cardiac death. Curr Cardiol Rep 2004;6:379.
10. Edouard DA, Pannier BM, London GM, Cuche JL, Safar ME. Venous and arterial behavior during normal pregnancy. Am J Physiol Heart Circ Physiol 1998;274: H1605.
11. Uhl K, Kennedy DL, Kweder SI. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs. Drug Safety 2002;25:885.
12. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001;49:200.
13. Perry BA, Turner LW. A prediction model for polypharmacy: Are older, educated women more susceptible to an adverse drug event? J Women Aging 2001;13:39.
14. Turnhein K. Drug treatment in the elderly. Pharmacokinetic and pharmacodynamic considerations. In: Mallarkey G, ed. Drug treatment considerations in the elderly. Auckland: ADIS International, 1999:35.
15. Hare GT, Reinhard SC, Brick JH, et al. Polypharmacy. Reducing adverse events among the elderly in NJ. NJ Med 1999;96:35.
16. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18,820 patients. Br Med J 2004;329:15.
17. Huang SM, Lesko LJ. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: What have we learned? J Clin Pharmacol 2004;44:559.
18. World Health Organization. Drugs for the elderly, 2nd ed. Copenhagen: WHO, 1997:5.
19. Blenkiron P. The elderly and their medication: Understanding and compliance in a family practice. Postgrad Med J 1996;72:671.